Jason Scott Slakter, Chief Executive Officer at Ohr Pharmaceutical Inc (OHRP), bought 6,350 shares at $3.92 ($23K) on 2016-01-19, disclosed to the SEC on 2016-01-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.52 | 200 | $704 | 3.1% |
| 2 | $3.52 | 100 | $352 | 1.5% |
| 3 | $3.52 | 100 | $352 | 1.5% |
| 4 | $3.53 | 1,000 | $4K | 15.4% |
| 5 | $3.54 | 1,200 | $4K | 18.5% |
| 6 | $3.55 | 850 |
| $3K |
| 13.1% |
| 7 | $3.56 | 100 | $356 | 1.6% |
| 8 | $3.57 | 100 | $357 | 1.6% |
| 9 | $3.59 | 400 | $1K | 6.3% |
| 10 | $3.60 | 200 | $720 | 3.1% |
| 11 | $3.65 | 200 | $730 | 3.2% |
| 12 | $3.66 | 200 | $732 | 3.2% |
| 13 | $3.67 | 200 | $734 | 3.2% |
| 14 | $3.70 | 100 | $370 | 1.6% |
| 15 | $3.73 | 200 | $746 | 3.2% |
| 16 | $3.75 | 400 | $2K | 6.5% |
| 17 | $3.81 | 500 | $2K | 8.3% |
| 18 | $3.88 | 200 | $776 | 3.4% |
| 19 | $3.92 | 100 | $392 | 1.7% |
| Total | $3.62 avg | 6,350 | $23K | 100% |
| Filing → |
| OHRP | BUY | 2016-05-26 | $11K | — | Filing → |
| OHRP | BUY | 2016-05-25 | $89K | — | Filing → |
| OHRP | BUY | 2016-04-12 | $21K | — | Filing → |